Hydrocortisone Diffusion Through Synthetic Membrane, Mouse Skin, and Epiderm™ Cultured Skin

Archives of Drug Information

Volumn 4, Issue 1, 2011, Pages 10-21

  Christensen, John Mark ^a   Chuong, Monica Chang ^b   Le, Hang ^c   Pham, Loan ^a   Bendas, Ehab ^d  

^a OREGON STATE UNIVERSITY   (United States)

^b MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^c Cairo University ^*  (United States)

^d CAIRO UNIVERSITY   (Egypt)

Author keywords

EpiDerm ; Fick's Law; Franz Cell; Gel; Higuchi Equation; Hydrocortisone Topical Products; Permeability

Indexed keywords

AVEENO; CORTICOOL; CORTIZONE 10; HYDROCORTISONE; HYDROCORTISONE ACETATE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; ARTIFICIAL MEMBRANE; CREAM; DRUG DIFFUSION; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; GEL; HUMAN; HUMAN CELL; KERATINOCYTE; LOTION; MEMBRANE FILTER; MOUSE; NONHUMAN; OINTMENT; PRIORITY JOURNAL; SKIN CULTURE; SKIN PERMEABILITY; SKIN WATER LOSS;

EID: 79951805621     PISSN: None     EISSN: 17535174     Source Type: Journal    
DOI: 10.1111/j.1753-5174.2010.00033.x     Document Type: Article

References (22)

1. Radoja N, Komine M, Jho SH, Blumenberg M, Tomic-Canic M. Novel mechanism of steroid action in skin through glucocorticoid receptor monomers. Mol Cell Biol 2000;20:4328-39.
2. Schafer KM, Kleuser B, Ahmed M, Holtje HD, Korting HC. Glucocorticoids for human skin: New aspects of the mechanism of action. Skin Pharmacol Physiol 2005;18:103-14.
3. Shah VP, Elkins J, Hanus J, Noorizadeh C, Skelly JP. In vitro release of hydrocortisone from topical preparations and automated procedure. Pharm Res 1991;8:55-9.
4. Mattek Corp. E.s.m. Available at: (accessed January 5, 2011).
5. Bronaugh RL, Stewart RF, Congdon ER. Methods for in vitro percutaneous absorption studies II: Animal models for human skin. Toxicol Appl Pharmacol 1982;62:481-8.
6. Priborsky J, Muhlbachova E. Evaluation of in-vitro percutaneous absorption across human skin and in animal models. J Pharm Pharmacol 1990;42:468-72.
7. Schmook FP, Meingassner JG, Billich A. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. Int J Pharm 2001;215:51-6.
8. Shah VP, Elkins JS, and Williams RL. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products. Pharm Dev Technol 1999;4:377-85.
9. Shah VP, Elkins JS. In vitro release from glucocorticosteroid ointments. J Pharm Sci 1995;84:1139-40.
10. Shah VP, Elkins JS, Lam SY, Skelly JP. Detemination of in vitro drug release from hydrocortisone creams. Int J Pharm 1989;53:53-9.
11. Sankar V, Praveen C, Prasanth KG, Srinivas CR, Ruckmann K. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with a commercial cream. Pharmazie 2009;64:731-4.
12. Wester RC, Maibach HI. In vitro testing of topical pharmaceutical formulation. In: Bronaugh RL, Maibach H, eds. Percutaneous absorption. 2nd edition. New York: Marcel Dekker; 1989:653-9.
13. Brain KA, Walters KA, and Watkinson AC. Methods for studying percuteneous absorption. In: Walters KA, ed. Dermatological and transdermal formulations. New York: Marcel Dekker; 2002:197-270.
14. Netzlaff F, Lehr CM, Wertz PW, Schaefer UF. The human epidermis models EpiSkin, SkinEthic and EpiDerm: An evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity and substance transport. Eur J Pharm Biopharm 2005;60:167-78.
15. Chatterjee A, Babu RJ, Klausner M, Singh M. In vitro and in vivo comparison of dermal irritancy of jet fuel exposure using EpiDerm™ (EPI-200) cultured human skin and hairless rats. Toxicol Lett 2006;167:85-94.
16. Gohel MC, Panchal MK, Jogani VV. Novel mathematical method for quantitative expression of deviation from the higuchi model. AAPS PharmSciTech 2000;1.
17. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J Pharm Sci 1961;50:874-5.
18. Elias PM, Cooper ER, Korc A, and Brown BE. Percutaneous transport in relation to stratum corneum structure and lipid composition. J Invest Dermatol 1981;76:297-301.
19. Hadgraft J, Guy RH. Feasibility assessment in topical and transdermal delivery: Mathematical models and in vitro studies. In: Guy R, Hadgraft J, eds. Transdermal drug delivery. 2nd edition. New York: Marcel Dekker; 2003:1-23.
20. Sinko PJ. Diffusion. In: Sinko PJ, ed. Martin's physical pharmacy and pharmaceutical sciences. 5th edition. Lippincott Williams & Wilkins; 2006:301-35.
21. th edition. Thousand Oaks CA: Pine Forge Press, an Imprint of SAGE Publications. Inc; 2009:493-4.
22. Bamba FL, Wepierre J. Role of the appendageal pathway in the percutaneous absorption of pyridostigmine bromide in various vehicles. Eur J Drug Metab Pharmacokinet 1993;18:339-48.